https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00061 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100318404-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b2acf00302 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d4w008aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w004ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd20145b-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00081 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00091 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m102a8708 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m102a8709 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p109m6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b3ake00402-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b2akf00263 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00101 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-15 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-16 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100318947 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b3akf00362 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b2akf00263-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00101-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-f2w001am 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-f2w014aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100318947-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b3akf00362-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-t4aff00891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-t4aff00761 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-d4aff00961 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a4afe03621 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a4aff00401 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-b4afe05991 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100318404 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100324186 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100338188 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100348686 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a1naf00122 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a1ncf00072-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00111 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-b4gdf00091 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a4afe05061 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a4aff02651 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500iu-injection-a1nbf00092 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500iu-injection-a1nbf00132 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w009ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d4w017aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d4w014ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b1akf00323 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-powder-and-solvent-solution-intravenous-injection-500u-f2w025aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k112e2815 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m113a1203 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00151 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m122a8706 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d4w017aa-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w001aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a4xbe00122 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a1ncf00112 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b3ake00862 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/prothrombinex-vf-3280920596 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/prothrombinex-vf-3280920598 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d4w020ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m122a870g 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b3acf00322 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a1naf00152 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a1ncf00162 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-k124c6644 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a1naf00202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-17 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w014ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p120a6646 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b2akf00483 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500iu-injection-a1nbf00192 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250iu-injection-a4naf00162 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b2acf00542 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352c21001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-18 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100380371 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00141 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a4gbf00161 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff03941 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100387022 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m140a8702 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff03891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff03951 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04121 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04131 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04141 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04151 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04301 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a1xbf00022 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04391 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100379003 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t21013 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8w116ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8w112ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t21016 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p120a6646-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m140a8707 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04f002271 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04f002281 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100378997 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04541 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b01f018543 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01f000212 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a1nbf00312 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100402169 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04f011902 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04f014801 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a01f009862 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01f015012 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01f015032 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01f012342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b01f018572 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8w145ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100398721 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100400115 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b3acf00582 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a1nbf00272 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a1nbf00282 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a1ncf00172 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a1xbf00032 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e4gdf00181 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100387022-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd21329a 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04f008481 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w027aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551170 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501558 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851076 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b21002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04f008471 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g4aff04581 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-19 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-powder-and-solvent-solution-intravenous-injection-20 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g003901 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g003881 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p203a6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m201c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m201c1203 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x007ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x021ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100411621 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a01f009912 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500iu-injection-a01f001782 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d6w027aa-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x007ac-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m202a1207 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m209a8703 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m206a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m206b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g003921 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04f014791 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01g015362 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k207a2813 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k207a2817 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m208a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m209a8708 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551194 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851086 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501574 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x002ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x042ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x050ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100446661 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p214a6649 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x009af 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100450542 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t21016-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501574-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22001-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100451244 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100451857 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100452024 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100447653 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g022891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g069521 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g026041 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x050ab-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x059ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04f013732 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g006072 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01g000692 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100461472 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p215b6869 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p222m6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100466451 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x016aaa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22002-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22003 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x006ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x076ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x077ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b03g026143 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m223a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m224a8707 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100469640 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h21006 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t21023 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01g017342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03g026322 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03g033242 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01g010922 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a1nbf00322 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g034922 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g031322 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03g041082 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x016aag 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd22180a 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100469682-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100461904 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04g079021 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g069531 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g069541 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g069561 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x076ac-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22003-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22004 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a01g031342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x077ae-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100470869 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100472779 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m211d1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m221a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m226b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04g088841 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g082141 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100475891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x102ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100480037 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100481755 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04g079011 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22004-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22005 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01g031882 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g043092 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p226m6642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p224m6648 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p232c6665 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-25-250-gl-solution-infusion-l208a6676 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x018al 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04g099171 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k237a2812 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g046592 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x010ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x102ac-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22005-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22006 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-a03g067543 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100489897 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04g088881 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04g096061 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100495865 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100500351 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100495888 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551218 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551218-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501596 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851100 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g029231 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x023ap 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x014aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01g065042 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p242a6863 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p243a6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100509966 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h21007 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2x038ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22007 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22007-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k245a2811 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04g131861 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04g118421 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04g131871 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-25-250-gl-solution-infusion-k247a6672 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100515233 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100515235 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h21007-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h21007-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x102ac-3 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100510798 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100519086 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p247a6648 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-352b22008 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b02g069962 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b01g070012 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m245a8701 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-injection-k252f2812 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-k240c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b01g108743 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100523097 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x157ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8x163ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x014aa-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x018ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a007ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-e04h009821 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357r23001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-3470551234 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501610 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a04g071972 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g073352 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100542740 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851102 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-3470551234-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501610-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a01h006302 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03h004112 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b23002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9x018ae-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a005ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a004ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-250-iu-injection-a04h003812 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9a001ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a004ab-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a020ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h028501 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b23003 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a006ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04g046692 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-072-human-albumin-grifols-2050ml-e04h025131 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-073-human-albumin-grifols-2050ml-z04h009921 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-074-octaplex-powder-and-solvent-solution-injection-k301f2811 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-075-octaplex-powder-and-solvent-solution-injection-k252f2816-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-076-albunorm-5-50-gl-solution-infusion-p301a6644 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-077-alphanate-500-iu-injection-a01g045132 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-078-feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-079-alphanate-500-iu-injection-a01g067152 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-080-rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100494722 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-081-privigen-solution-infusion-10-p100539305 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-082-privigen-solution-infusion-10-p100539712 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-083-flebogamma-5-dif-g04h032731 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-084-human-albumin-grifols-2050ml-g04h028521 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-085-human-albumin-20-behring-low-salt-solution-infusion-p100550742 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-086-fibryga-1g-powder-and-solvent-solution-injection-or-infusion-m246a3473 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/lrc-pp-087-iv-globulin-sn-inj-50mgml-357b23004 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd23035a 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g049082 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100550742 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100551272 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b02h012372 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01g053282 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01h014952 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357c23005 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m238b1204 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100562609 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100565500 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a014ag 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100562607 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p312c6662 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m252c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h048891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/haemocomplettan-p-1g-powder-solution-injection-infusion-p100340466 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100579155 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m314c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b23006 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-e04g131871-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100583801 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100583633 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p301a6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b02h032232 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100564571 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-5-human-albumin-5-solution-p100594447 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100598726 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a025aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h063101 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h065701 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h070371 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01g049082-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a096aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a094aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501622 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501630 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100594490 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551256 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851108 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p313a6669 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a01h008982 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b23007 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04h046521 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h066821 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h070361 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a025af 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a096aa-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9a010ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a04g068392 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01g053282-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100592167 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k323a2842 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m315a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04h026692 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h065691 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h086001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100603658 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p307a6647 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b23008 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k323a2842-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2a026ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p319b6864 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-25albumin-human-50ml-b01h047712 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd23128 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h106001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h089701 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01h046562 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100608881 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357r23009 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100608879-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100609012 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357r23500 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-k327a1204 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h110071 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01h055312 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357r23009-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k326a2842 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8a152aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100619125 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100629652 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04h031772 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3a069ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100626616 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3a054ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3a052ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100634752 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h150891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04h162271 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-p-3740501630-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-human-albumin-20-200-gl-3470551264 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851110 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p336b6642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100641607 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100643397 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m340c1205 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m345b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3a082aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3a091ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3a101al 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-k327a1205-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd23294e 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-b06j002233 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100634748 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100638793 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100644010 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h172741 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04h169361 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100649524 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100650674 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h169331 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j006181 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p351d6662 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m346e1202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m347e1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m348c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01h046562-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100639926 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b005ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-5-human-albumin-5-solution-p100650654 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k402a2843 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j014991 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h169141 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j005981 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j025351 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04h129361 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j013512 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j013912 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03h086822 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j004162 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j014912 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j004132 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j019642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m401a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-sk3j028313 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octagam-5-solution-infusion-k404c8442 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/fanhdi-250iu-a04h100341 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t23002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h24001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p403b6662 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-g04j020621 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04j016481 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04h066142 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a01h006282 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b001aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-m412a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01j003232 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j021942 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j021952 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j024022 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100672084 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3a093ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b027aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b029aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b024ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/fibryga-1g-powder-and-solvent-solution-injection-or-infusion-m319a3492 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100669809 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j064951 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/fibryga-1g-powder-and-solvent-solution-injection-or-infusion-m411b3491 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b018ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k413b2846 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b015ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100681723 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100710141 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-25-250-gl-solution-infusion-k414a6671 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m418a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m419a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m416a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m416b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100710142 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100709319 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b069aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9b009ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b082ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b029ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b038ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b034ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b046ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m419a1202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m416b1206 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m417b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p406a6642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-nexgen-20-solution-intravenous-infusion-p100669317 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-nexgen-10-50ml-solution-intravenous-infusion-p100672851 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100709970 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-m406a8708 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b046af-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b045ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b041ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100708108-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100681723-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100712233 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100709875 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851118 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-nexgen-10-50ml-solution-intravenous-infusion-p100696810 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-nexgen-solution-intravenous-infusion-p100708212 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t23002-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-nexgen-10-50ml-solution-intravenous-infusion-p100723641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-nexgen-20-solution-intravenous-infusion-p100726705 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04j019632 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b046ag 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b054ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b067ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b025ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd24091d 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b124aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b137aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/iv-globulin-sn-inj-50mgml-357b24501 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h24002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b054ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b067ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b074aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b026ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100733638 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-20-gcc-212c24031 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-human-usp-albuteinr-20-solution-infusion-a04h070742 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j059402 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j061562 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-k417b284e 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j051001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j057961 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-p421b6641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b025aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/intragam-nexgen-10-50ml-solution-intravenous-infusion-p100723640 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-nexgen-20-solution-intravenous-infusion-p100720892 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumex-20-nexgen-20-solution-intravenous-infusion-p100720894 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/biostate-human-coagulation-factor-viii-powder-injection-3300851116 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j059391 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a04j009632 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-a02j050492 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m422f1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m420d1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-b03j032923 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j141721 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a02j080072 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd24320 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j137561 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j137661 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j150051 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j153721 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j153731 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-k437a6642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-20-gcc-212c24031-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100733997 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m440a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m441a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m441d1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b093aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2b041ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b210aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9b027ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b074ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j158401 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j162491 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04j159331 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100732477 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100751085 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100779098 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j084812 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t24010 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-230h24003 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b074ag 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b079ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b096ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b082ag 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b222ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100716298 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100759462 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100739907 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b02j089382 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b02j089362 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m449a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-g04j170071 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j166401 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j180481 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a01j065652 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b096ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b100ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m445c1207 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m446a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-m451b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j158361 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04j119561 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b150ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8b153aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9b023ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-a03j090913 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100729491 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100716298-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b01j072732 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j074792 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03j059392 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b070aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b03j094513 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a03j087002 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9c001ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c019ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b110ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-100-iuml-powder-and-solvent-solution-injection-c3b119ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3b100aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c001ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03k005722 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04j183941 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-l452c2643 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-b01j061732 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c020ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2c005ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50uml-injection-m451d1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50uml-injection-m452a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50uml-injection-m451b1202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-a04j119361 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-a04j180351 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100802193 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a02j076972 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-b03j032923-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100754928 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp04a1202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp04a1203 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-p445e6664 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100803702 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a02j090892 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9c001ac-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t24014 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd25026 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h25001 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c020af 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c022ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04k049751 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03k018382 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03k018392 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b03k018522 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100816092 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100816100 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp03a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-g04k044641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-a02k032213 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k011022 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-g04k049271 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a04k017352 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100816092-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100826060 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c044ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c057ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9c001ac-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100803702-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100820114 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c057ad-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100831457 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100831458 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp04a1204 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp1301201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp14a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a03k017372 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd25026-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-20-50ml-a04k015751 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b21k038483 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k057611 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k054011 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c022aj 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/immunate-50-iuml-powder-and-solvent-solution-injection-c3c033ae 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp12a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp12b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100838964 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100838073 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k034252 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k059211 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100827134 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100832916 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04k093491 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c057ad-3 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c081aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9c008ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp12c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp13c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp16b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp09b1203 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp13a1202 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c081aa-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-kp11b6642 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100852342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h250012 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp18a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp24a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a02k035482 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k053352 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b13k069053 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100838964-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100846407 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k075891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k076931 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04k104601 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k049552 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k032392 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k021502 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a02k034232 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a02k025142 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c102aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/sero-tet-injection-081t24017 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c107aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c108aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k084291 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-20-gcc-212c24054 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a03k050932 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100866620 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-lp35a2641 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k138891 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k090411 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k045562 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100880939 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100867028 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100867277 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k090401 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp41c1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100895186 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100895187 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k067682 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a02k069342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c142aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c156aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c158aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/artiss-solutions-sealant-deep-frozen-d9c016aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100866620-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-500-iu-injection-a02k055022 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hepabig-injection-100iu-05ml-vial-230h25001-3 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k093231 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k100161 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k054602 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp42a1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100895187-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100899193 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-human-albumin-200gl-solution-infusion-ahd25382 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp41c1201-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp42a1201-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50iuml-injection-mp41b1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k114751 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k146471 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k157661 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c172aa 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c170ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-5-50-gl-solution-infusion-kp40a6645 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albunorm-20-200-gl-solution-infusion-pp38a6863 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100918106 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k054612 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k057702 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k063132 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k161921 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100888543 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/plasbumin-25-50ml-vial-b14l005653 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13k063102 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-100iuml-injection-mp41d1201 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8d009ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100933688 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/fibryga-1g-powder-and-solvent-solution-injection-or-infusion-mp49c3492 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8d022ac 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k191221 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-g04k191231 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-lq02b2645 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alburx-25-human-albumin-25-solution-p100739907-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhophylac-300-microgram2mlsolution-injection-pre-filled-syringe-p100866620-3 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04l014651 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04k189611 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k166121 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k162081 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b11l012342 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100940595 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100942916 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/gamunex-c-immune-globulin-injection-human-10-caprylatechromatography-purified-b03k108253 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a02l002132 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-human-albumin-200gl-solution-infusion-ahd25382-2 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04l029951 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04k155861 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a03l004801 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/hizentra-200mgml-solution-subcutaneous-injection-p100941134 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-human-usp-albuteinr-20-solution-infusion-a02k088372 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanate-1000-iu-injection-a02k050902 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04l004761 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04l004791 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albutein-5albumin-human-250ml-b13l021172 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octaplex-powder-and-solvent-solution-infusion-lq07a2644 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/feiba-factor-viii-inhibitor-bypassing-activity-25uml-powder-and-solvent-solution-infusion-f2d003ad 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04l004751 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100961943 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100961971 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/flebogamma-5-dif-a04l029961 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-grifols-2050ml-a04l018401 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100952311 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/privigen-solution-infusion-10-p100899193-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/alphanine-injection-sd-500-iu-a1xbb00032-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/rhesonativ-625-iuml-solution-injection-lot-m747a8704 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/octanate-50-iuml-injection-m749b1201-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/human-albumin-20-behring-low-salt-solution-infusion-p100020752-0 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/albumin-20-gcc-211c18505 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/zenalb-20-50ml-20-human-albumin-ahd19269 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-pp-0032024-albumin-20-gcc-212c23507 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/tisseel-fibrin-sealant-frozen-solution-d8c010ab 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012014-hepavax-gene-tf-20mcg10ml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022014-euvax-b-injection-10mcg05ml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032014-euvax-b-injection-10mcg05ml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0042014-euvax-b-injection-10mcg05ml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0052014-euvax-b-injection-10mcg05ml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022016-priorix-vaccine-mmr 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032016-priorix-vaccine-mmr 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012017-gardasil-suspension-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022017-mmr-ii-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032017-mmr-ii-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0042017-varivax-refrigerated-varicella-virus-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0052017-cervarix-suspension-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0062017-synflorix-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022018-freeze-dried-glutamate-bcg-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032018-freeze-dried-glutamate-bcg-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012019-freeze-dried-glutamate-bcg-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022019-freeze-dried-glutamate-bcg-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012018-menactra-solution-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012020-zostavax-zoster-vaccine-live-okamerck-msd 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012023-typhim-vi-single-dose 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-pp-0012022-iv-globulin-sn-inj-50mgml 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0042021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0052021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0062021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0072021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0082021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0092021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0102021-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0012022-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022022-comirnaty-concentrate-dispersion-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022023-mmr-ii-vaccine 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0022024-cervarix-suspension-injection 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/lot-release/certificates/nnc-0032024-verorab-vaccine-x1b783m 2026-08-10T04:26:05+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xgevar120mg-solution-injection-denosumab-updated-recommendations-minimise-risk-severe-symptomatic 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/artrodarr50mg-diacerein-new-restrictions-use-limit-risk-severe-diarrhoea-and-effects-liver 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminylr-galantamine-hydrobromide-new-warning-serious-skin-reactions-stevens-johnson-syndrome-sjs 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/topamaxr-topiramate-updated-warnings-and-precautions-visual-field-defects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/revatior-sildenafil-citrate-safety-information-regarding-revatior-tablets-treatment-pulmonary 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/neupogenr-filgrastim-neulastimr-pegfilgrastim-risk-capillary-leak-syndrome-patients-cancer 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/protaxosr-strontium-ranelate-new-restricted-indication-and-contraindications-use 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/granr-filgrastim-peglastar-pegfilgrastim-risk-capillary-leak-syndrome-patients-cancer-filgastrim 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ritalin-and-ritalin-lar-methylphenidate-hydrochloride-new-warning-priapism-patients-treated 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mencevax-acwytm-meningococcal-vaccine-new-antibody-persistence-data 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/vectibixr-panitumumab-rare-cases-stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/risperidone-and-paliperidone-risk-intraoperative-floppy-iris-syndrome-ifis-patients-undergoing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/dilatrendr-carvedilol-warning-severe-adverse-cutaneous-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/combination-products-containing-cyproterone-acetate-2mg-and-ethinylestradiol-0035mg-restriction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/frisiumr-clobazam-update-include-serious-skin-reactions-package-insert-malaysia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ultracetr-tablet-tramadol-and-paracetamol-association-serious-skin-reactions-stevens-johnson 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/erbituxr-cetuximab-importance-establishing-wild-type-ras-status-exons-234-kras-and-nras-treatment 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/zofranr-ondansetron-dose-dependent-qt-interval-prolongation-updated-information-posology-intravenous 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/concertar-methylphenidate-hydrochloride-new-warning-priapism-patients-treated-attention-deficit 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tykerbr-lapatinib-comparative-data-have-shown-lapatinib-based-regimens-are-less-effective 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/1st-malaysia-japan-symposium 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/checklist-analytical-method-validation-chemical-and-microbiological 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/technical-error-adverse-drug-reaction-email 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ispe-malaysia-gmp-conference-10-11-february-2015-programme-registration-form 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-maajun-tolak 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-jenama-hans-beauty-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tambahan-indikasi-yang-diluluskan 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-sf-protect-perfect-day-cream-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-dnars-magic-gold-foundation-dan-yellow-cream-krim-ku-neng-telah-dikesan-mengandungi-racun 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/skyline-al-taqwa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/majun-burung-unta-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-november-2014 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ispe-malaysia-gmp-conference-10-11-february-2015-new-dates-programme-registration-form 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-jenama-dermaceutic-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-september-2014 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/collagen-slim-dan-beautiful-slim-body-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/slide-presentation-analytical-method-validation-and-method-validation-seminar 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/figure-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-july-2014 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-may-2014 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/jingzhi-yinqiao-jiedu-tablet-260-mg-pembatalan-pendaftaran-produk-tradisional-atas-sebab-campur 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invitation-intersessional-meeting-accsq-tmhs-pwg-and-its-related-meetings-25-29-aug-bangkok-thailand 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-jenama-beauty-dan-golden-horse-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/delima-raja-uratamaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-sensual-meiji-skin-renewer-cream-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cosa-grande-platinum-capsule-350mg-dan-vita-essence-capsule-pembatalan-pendaftaran-produk 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/oxyelite-pro-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/madu-adunan-herba-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-madu-adunan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/majun-dua-istimewa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/majun-taufiq-dua-istimewa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/figure-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-surat-khabar-nanyang-siang-pau-bertarikh-24-ogos-2013-bertajuk-niu-huang 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/china-press-majun-burung-unta 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-akhbar-star-bertarikh-9-september-2013-bertajuk-unlicensed-lipstick-may 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-surat-khabar-harian-metro-31-mei-2013-bertajuk-ubat-tahan-sakit-boleh 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/semi-manual-submission-procedure-applications-registration 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-kenyataan-akhbat-sin-chew-daily-bertarikh-10-julai-2013-bertajuk-2 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-may-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-kenyataan-akhbar-melecur-disapu-krim-kurus-sinar-harian-14-jun-2013 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-maajun-kuat 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tiga-produk-kosmetik-telah-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kerja-kerja-kecil-pusat-kawalan-kualiti-di-biro-pengawalan-farmaseutikal-kebangsaan-kementerian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-akhbar-china-press-bertajuk-tong-ren-tang-jian-ti-wu-bu-wan-contains-high 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-kenyataan-akhbar-berita-harian-bertajuk-nasihat-usah-guna-produk-kosmetik-tabita 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kosmetik-jenama-cellnex-natural-99-dan-sf-beauty-telah-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/perkhidmatan-sewaan-mesin-fotostat-penyalin-dan-caj-bacaan-meter-bagi-tempoh-dua-2-tahun-di-biro 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/joint-press-release-moh-malaysia-standards-malaysia-acceptance-malaysia-non-oecd-member-adhering-mad 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-artikel-dalam-sin-chew-daily-bertajuk-yin-ni-whitener-repair-cream-contains-high-level 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-dg-health-cancellation-registration-traditional-product-sta-lions 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/21st-asean-consultative-committee-standards-and-quality-accsq-pharmaceutical-product-working-group 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/empat-produk-kosmetik-telah-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-updates-anti-malarial-medicines-mmv 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-china-sin-chew-daily-27-februari-2013-3-unregistered-health-supplement 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/produk-kosmetik-yang-dibatalkan-notifikasi-atas-isu-campurpalsu 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-china-press-1-februari-2013-bertajuk-france-banned-sale-oral 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-consumers-cautioned-against-using-cosmetic-product-containing-scheduled-poison 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-list-cosmetic-products-containing-scheduled-poison 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/list-updates-gdp-guideline-2nd-edition-2013 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-jin-fei-cao-san-extract-powder-sheng-chang-cancelled 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-mymen-plus-capsule-400mg-cancelled 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keperluan-kajian-bioekuivalens-be-bagi-semua-produk-generik 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-reviews-quban-shuang-products-mercury 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-tarikbalik-dua-produk-pengilat-kuku-jenama-skin-food-yang-dikesan-mengandungi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-statement-produk-kosmetik-yang-dikesan-mengandungi-merkuri 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-statement-pao-ni-kang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-penggantungan-pendaftaran-produk-produk-yang-mengandungi-sibutramine-atas-sebab 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/status-keselamatan-terkini-bagi-ubat-rawatan-penyakit-diabetes-avandiar-rosiglitazone-avandametr 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-laporan-oleh-hong-kong-consumer-council-berkenaan-produk-pewarna-kuku-yang-dikesan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/membekal-30-unit-komputer-peribadi-untuk-kegunaan-pegawai-di-biro-pengawalan-farmaseutikal 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/traditional-product-twee-hong-suah-recalled 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/review-press-statement-regarding-johnsons-baby-shampoo-products 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumbalas-akhbar-mylotargr-leukemia-pfizer-resulted-high-mortality-rate-united-states-banned-its 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-statement-cosmetic-products-which-have-been-found-contain-scheduled-poison-derma-rx-arbutin-r 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-pengguna-dinasihatkan-untuk-mengelakkan-dari-mengguna-produk-kosmetik-yang-dikesan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berbentuk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-bagi-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-release-animal-testing-and-compliance-good-laboratory-practice-glp-organisation-economic-co 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-akhbar-kosmo-8-mac-2011-ancaman-syampu-guna-bahan-pencuci-lantai 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-tradisional-po-chai-pills-yang-disyaki-tiruan-di-campur-palsu-dengan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/malaysian-variation-guideline-tmhs-draft-13-and-presentation-slides-training-course-malaysian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/21st-asean-consultative-committee-standards-and-quality-pharmaceutical-product-working-group-meeting 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berkaitan-dengan-increased-risk-opportunistic-infections-such-activation-latent 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-penjualan-produk-tidak-berdaftar-amberine-capsule 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-penjualan-produk-tidak-berdaftar-357-nasal-spray 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berkaitan-dengan-severe-drug-interaction-between-colchicine-and-p-glycoprotein-or 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/jingzhi-keshou-tanchuan-pill-registered-malaysia-safe-consumption 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-pengguna-dinasihatkan-untuk-mengelakkan-dari-mengguna-produk-produk-kosmetik-yang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-keselamatan-produk-minyak-ikan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-tawaran-sebut-harga-bagi-pembekalan-consumable-items-dan-bahan-reagen 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berkaitan-dengan-potential-increase-risk-hepatotoxicity-yang-perlu-dimuatkan-pada 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/status-keselamatan-produk-berdaftar-poh-chai-pill 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kehadiran-fragmen-dna-porcine-circovirus-1-pvc-1-di-dalam-vaksin-human-rotavirus-hrv-rotarix 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/panggilbalik-produk-po-chai-pills-oleh-health-sciences-authority-hsa-singapura-dan-department 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-oleh-ketua-pengarah-kesihatan-ke-arah-perkhidmatan-farmasi-yang-cemerlang 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-pengguna-dinasihatkan-mengelak-dari-mengguna-produk-produk-kosmetik-yang-dikesan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/status-keselamatan-terkini-bagi-ubat-rawatan-penyakit-diabetes-avandiar-rosiglitazone 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berkaitan-dengan-possible-interaction-between-clopidogrel-and-proton-pump 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penjualan-produk-tidak-berdaftar 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-amaran-berkaitan-dengan-potential-increase-risk-suicidal-thoughts-or-behaviours-yang-perlu 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/untuk-sebaran-serta-merta-oleh-pihak-berkuasa-kawalan-dadah-pbkd-kementerian-kesihatan-malaysia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumbalas-kepada-keratan-akhbar-sin-chew-daily-popular-non-prescription-drug-us-and-uk-alli-weight 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-larangan-penggunaan-produk-yang-dinotifikasikan-sebagai-produk-kosmetik-tetapi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pindaan-pada-kenyataan-amaran-berkaitan-dengan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-keselamatan-mengenai-produk-antimokrobial-sistemik-kumpulan-fluoroquinolones 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/current-regulatory-system-oic-member-states-survey-form 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/amaran-kepada-pemegang-pendaftaranpengilang-yang-membuat-perubahan-pada-ubat-berdaftar-tanpa 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penggantungan-produk-sibutramine-oleh-european-medicine-agnecy-ema 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-keselamatan-produk-champix-varenicline-berkaitan-kesan-advers 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/metoclopramide-maklumat-keselamatan-mengenai-penggunaan-pada-kanak-kanak 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cosmetic-seminar-organized-ctfa-collaboration-bpfk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/larangan-penggunaan-bahan-pewarna-dalam-produk-mengandungi-bahan-aktif-prednisolone-dalam-bentuk 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/amaran-dari-us-food-drug-administration-usfda-berkaitan-penggunaan-ubat-untuk-rawatan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/products-containing-nimesulide 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/suspension-products-containing-nimesulide 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/drug-control-authority-statement-cardiac-safety-rosiglitazone-avandia 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/larangan-penggunaan-bahan-premix-dalam-formulasi-produk-semulajadi-tradisional 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-safety-concerns-relating-use-zelmac 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/bengkel-sehari-bersama-hempedu-bumi-penerapan-kawalan-kualiti-dalam-bahan-mentah 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/labelling-derived-seafood 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/qmax-kapsul-350-mg 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/products-containing-ace-inhibitors 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/health-supplements-containing-arginine 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tawaran-sebutharga-kerja-kerja-menaiktaraf-lif-di-bangunan-blok-a2-biro-pengawalan-farmaseutikal 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kintop-capsule 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/products-containing-black-cohosh-related-serious-hepatic-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/registration-products-gatifloxacin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/products-promethazine-hydrochloride 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tawaran-sebutharga-kerja-kerja-menaiktaraf-infrastruktur-dan-pendawaian-kantin-di-blok-b-biro 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-kepada-laporan-dalam-kenyataan-akhbar-utusan-malaysia-bertarikh-19-september-2013-pengawet 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-tawaran-sebutharga 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pembayaran-caj-pemeriksaan-amalan-perkilangan-baik-apb-yang-dijalankan-oleh-bpfk-ke-atas-pengilang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/slides-national-regulatory-conference-2013 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/national-regulatory-conference-2013-registration-closed 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pembaharuan-notifikasi-kosmetik 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/communicate-our-director-general-dg-health-malaysia-facebook 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelaksanaan-keperluan-sistem-air-terawat-dan-pengudaraan-berpusat-di-premis-pengilang-tradisional 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/panduan-pelaporan-aduan-produk-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-dan-pelaporan-kesan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-vetting-medicines-advertisement 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/borang-permohonan-pelan-aliran-premis-pengilang-barutambahan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/senarai-pengilang-veterinar-yang-telah-diperiksa-dan-memenuhi-keperluan-apb-minima 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ulasan-laporan-akhbar-pharmaceutical-company-india-recalled-cholesterol-lowering-drug-found 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/classification-medical-device-drug-cosmetic-interface-mddci-product 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/14th-meeting-asean-tmhs-scientific-committee-atsc-and-related-meetings-accsq-tmhs-pwg-task-force 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/news-data-exclusivity 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengeluaran-sijil-apb-pengilang-kosmetik-kepada-negara-asean 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-news-be 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keperluan-mengemukakan-dokumen-sokongan-pengesahan-tahap-pencemaran-radioaktif-bagi-produk-yang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/regulatory-control-active-pharmaceutical-ingredients 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penggunaan-doktor-gigi-di-dalam-iklan-iklan-produk-pergigian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/produk-dengan-nama-tuntutan-dan-kegunaan-untuk-melansingkan-badan-tidak-dikelaskan-sebagai-produk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/guildelines-good-distribution-practice-gdp 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penguatkuasaan-keperluan-pelesenan-terhadap-premis-pengilang-tempatan-yang-mengilang-produk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/garispanduan-pendaftaran-produk-homeopati 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/slid-pembentangan-bagi-taklimat-ringkas-berkenaan-quest-3-modul-ctil-ctx 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/senarai-produk-kesihatan-yang-dicampur-palsu-dengan-racun-terkawal 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelancaran-fasa-ketiga-sistem-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelancaran-fasa-kedua-sistem-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keperluan-penetapan-had-lovastatin-dari-sumber-asli-dalam-produk-semulajadi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelancaran-modul-penilaian-penuh-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-lanjutan-tentang-spesifikasi-baru-untuk-ujian-kontaminasi-mikrobial 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/spesifikasi-baru-untuk-ujian-kontaminasi-mikrobial 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/presentation-slides-day-1-national-regulatory-conference-nrc-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/presentation-slides-day-2-national-regulatory-conference-nrc-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/presentation-slides-day-3-national-regulatory-conference-nrc-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/p02-p-european-perspective-orphan-medicinal-products-bruno-sepodes-august-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-rtc-kawalan-ubat-tradisional-dan-produk-kosmetik-2015-zon-sarawak 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-makluman-kepada-orang-awam-berkenaan-dokumen-palsu-surat-arahan-pemberhentian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notice-service-interruption-digicert-online-system-16-august-2015 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notice-preventive-maintenance-works-digicert-online-system 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/quest-system-compatibility-issue 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/motiliumr-domperidone-new-recommendations-minimise-cardiac-risks 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/forxigar-dapagliflozin-risk-diabetic-ketoacidosis-during-treatment-sodium-glucose-co-transporter-2 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/quest-system-direct-links 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/online-adverse-drug-reaction-adr-reporting-interruption 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-reaksi-drug-safety-news-september-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/vaccine-lot-release-panduan-bayaran-yuran-dan-slaid-pembentangan 2026-08-15T00:45:04+00:00 daily 0.9 https://npra-portal.demosistem.site/news/international-good-manufacturing-practice-training-program-2016-updated-18-jan-2016 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/perintah-cukai-barang-dan-perkhidmatan-pembekalan-berkadar-sifar-pindaan-no2-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/list-cosmetic-manufacturer-malaysia-conforms-requirement-good-manufacturing-practices-gmp-accordance 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cellceptr-mycophenolate-mofetil-teratogenic-risk-important-new-pregnancy-prevention-advice-women-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/good-distribution-practice-gdp-transporters 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/satu-produk-kosmetik-yang-dibatalkan-notifikasi-atas-isu-campurpalsu 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akbar-kawalan-kosmetik-di-malaysia 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-20-feb-2016-isu-kapsul-dari-daun-betik-minyak-kelapa-dara-beberapa-herba-lain 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/slides-regulatory-updates-2016 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-ispe-tmhs-dan-kosmetik 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/format-laporan-tindakan-pembetulan-dan-tindakan-pencegahan-capa-dan-nota-penerangan-format-laporan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-tradisional-el-biozing-dikesan-mengandungi-racun-berjadual-dexamethasone 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-tradisional-li-chung-pill-ubat-bebola-dikesan-mengandungi-alkaloid-bertoksik 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-15-april-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/slides-taklimat-quest3-untuk-industri-26-april-2016 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-tempoh-akhir-mengemukakan-dokumen-bagi-permohonan-baru-dan-variasi-pendaftaran-produk 2026-08-15T00:45:04+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-17-mei-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-ispe-tmhs-kosmetik-20 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xgevar-120mg-proliar-60mg-denosumab-clinically-significant-cases-hypercalcaemia-after-cessation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/viekiraxr-ombitasvir-paritaprevir-ritonavir-or-without-exvierar-dasabuvir-not-recommended-child-pugh 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xalkorir-crizotinib-inclusion-new-warning-regarding-cardiac-failure 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/glivecr-imatinib-tasignar-nilotinib-risk-hepatitis-b-reactivation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/locabiotalr-solution-fusafungine-withdrawal-registration-following-european-medicines-agencys 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penangguhan-pelancaran-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penangguhan-pelancaran-quest3-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemberitahuan-nama-bpfk-untuk-bank-deraf-kiriman-wang-wang-pos 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gangguan-talian-telefon-utama-npra 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelancaran-modul-kosmetik-notifikasi-quest3 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/user-manual-quest3-digital-certificate 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/adempasr-riociguat-new-contraindication-patients-pulmonary-hypertension-associated-idiopathic 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tarcevar-erlotinib-first-line-maintenance-indication-now-restricted-treatment-patients-whose-tumours 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/b2b-online-payment-transaction-flow 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-foreign-gmp-regulatory-inspection-managing-changes-licensed-facility 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-15-september-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-tradisional-aman-liquid-dikesan 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invokanar-canagliflozin-advice-risk-lower-limb-amputation-primarily-toe-during-treatment 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/implanon-nxtr-etonogestrel-implants-have-been-found-rarely-vasculature-and-lung-update-possible 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-asean-common-technical-dossier-actd-preparationgeneric-products-malaysian-submission 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/laporan-tahunan-npra-2015 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-gmp-training-2017 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/user-manual-quest3-system 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pra-pelancaran-sistem-quest3-modul-produk-farmaseutikal-closed 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-7-november-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-16-disember-2016-amaran-kepada-orang-awam-berkenaan-pengambilan-produk-tidak 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-penutupan-kaunter-unit-hasil-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-disember-2016 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penutupan-penerimaan-pendaftaran-secara-manual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-5-januari-2017-panggil-balik-produk-ternolol-50-film-coated-tablet 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/awasi-produk-tidak-berdaftar 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemberitahuan-permohonan-lesen-pengilang-lesen-mengimport-lesen-pemborong-senarai-tambahan-produk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-8-februari-2017-mesej-whatapps-tular-berkaitan-tablet-paracetamol 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-permohonan-pendaftaran-semula-pertukaran-pemegang-pendaftaran-dan-certificate 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pindaan-seminar-rtc-kawalan-ubat-tradisional-dan-produk-kosmetik-2017 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cosmetic-seminar-2017-28th-29th-march-2017 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/zaltrapr-aflibercept-information-risk-osteonecrosis-jaw 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pomalystr-pomalidomide-new-important-advice-hepatitis-b-virus-status-be-established-initiating 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hari-bersama-pelanggan-bahagian-regulatori-farmasi-negara-npra-2017 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-mengenai-penguatkuasaan-yuran-pemprosesan-permohonan-variasi-produk-pada-1-april-2017 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/escapeller-postinor-2r-levonorgestrel-levonorgestrel-containing-emergency-hormonal-contraception-new 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/madonnar-levonorgestrel-levonorgestrel-containing-emergency-hormonal-contraception-new-advice 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-11-april-2017-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updates-bioequivalence-be-webpage 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seranta-awam-cadangan-pindaan-peraturan-peraturan-kawalan-dadah-kosmetik-1984-pkdk-1984 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-berkenaan-penghantaran-borang-beserta-pembayaran-bagi-pengkelasan-pendaftaran-produk 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/revlimidr-lenalidomide-new-important-advice-regarding-viral-reactivation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/domider-thalidomide-new-important-advice-regarding-viral-reactivation-and-pulmonary-hypertension 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/migrasi-data-berperingkat-untuk-sistem-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/zelborafr-vemurafenib-important-drug-warning-risk-dupuytrens-contracture-and-plantar-fascial 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keytrudar-pembrolizumab-risk-stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-berkenaan-parking-pelawat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gentle-reminder-renewal-product-registration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-mengenai-kawalan-produk-persediaan-parenteral-sebagai-racun-di-bawah-akta-racun-1952 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cleanroom-behaviour-course 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penutupan-sistem-quest3 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-rtc-kawalan-ubat-ubatan-tradisional-dan-kosmetik-bernotifikasi-2017-zon-sarawak 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelaksanaan-proses-kerja-baharu-pemeriksaan-rangkaian-sejuk-bagi-aktiviti-vaccine-dan-plasma-product 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ispe-malaysia-gmpgdp-inspection-biopharmaceuticals-2017 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xgevar-denosumab-risk-multiple-vertebral-fractures-mvf-following-treatment-discontinuation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ribomustinr-bendamustine-increased-mortality-observed-when-used-non-approved-combination-treatments 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi-0 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seranta-awam-draf-garis-panduan-amalan-pengedaran-baik-edisi-ke-3-2018 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/workflow-manual-registration-export-only-feo-products 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pembukaan-section-s-e13-untuk-variation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/panggilan-sesi-dialog-perbincangan-draf-garis-panduan-amalan-pengedaran-baik-aeb-edisi-ketiga-2018 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penutupan-pembayaran-online-untuk-sistem-quest3-bagi-penutup-tahun-2017 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/surat-peringatan-pendaftaran-semula-produk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-training-international-good-manufacturing-training-program-2018 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/proses-pendaftaran-pengguna-untuk-sistem-pendaftaran-produk-perlesenan-quest-3 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi-1 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-penutupan-kaunter-kutipan-dan-terimaan-hasil-berikutan-penutupan-akaun-utama-pada-28-dis 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/lanjutan-tarikh-pelaksanaan-pemakaian-guideline-regsitration-drug-medical-device-and-medical-device 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-jun-2017 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-mac-2017 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/malaysian-herbal-monograph-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xofigor-radium-223-dichloride-important-safety-information-update-regarding-increased-incidence 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ofevr-nintedanib-information-severe-liver-injury-and-need-regular-monitoring-liver-function 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/application-combination-pack-combo-pack 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updates-foreign-gmp-regulatory-inspection-2019 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/quest3-system-usb-token-package 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/levetiracetam-and-methotrexate-risk-drug-drug-interaction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/intravenous-iv-fluids-containing-electrolytes-andor-carbohydrates-risk-hyponatraemia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gadolinium-based-contrast-agents-suspensionrestriction-use-following-evidence-gadolinium-deposits 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/doxycycline-risk-jarisch-herxheimer-reaction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-safety-alerts-healthcare-professionals 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-scam-panggilan-telefon 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-untuk-industri-pemeriksaan-apb-pengilang-veterinar 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/national-regulatory-conference-nrc-2018 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-september-2017-volume-69 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-december-2017-volume-70 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-march-2018-volume-71 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/2018-education-seminar-series-good-distribution-practice-gdp 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-2 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/esmyar-5-mg-tablets-ulipristal-acetate-women-taking-esmyar-uterine-fibroids-have-regular-liver-tests 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-e13-field-approved-product 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminder-successful-payment-status 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/quest3-system-security-upgrade 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/jadual-tempoh-permohonan-tempoh-kemaskini-bagi-data-cleaning 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-e13-field-approved-product-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelancaran-modul-feo-export-only-di-sistem-quest3 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/surat-peringatan-pendaftaran-semula-produk-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/data-cleaning-open-approved-products-submit-manually 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/variation-open-section-e13-section-s 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/enable-export-button-using-google-chrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/workflow-manual-registration-export-only-feo-products-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penutupan-sistem-lama-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengumuman-mengenai-penguatkuasaan-yuran-pemprosesan-permohonan-variasi-produk-pada-1-april-2017-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gentle-reminder-application-product-registration 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/check-addresses-registered-under-company-ensure-there-no-duplicated-address-or-inactive-address 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-scam-panggilan-telefon-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/acetazolamide-risk-severe-cutaneous-adverse-reactions-scars 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/announcement-prescription 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/submission-bioequvalence-be-study-reports-registered-generic-products-form-effervescent-dispersible 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/downloadable-forms-generic-medicines 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-tmhs-product-quality-review-pqr-dan-verifikasi 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/promosi-penjualan-monograf-herba-malaysia-2015 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/nrc-2018-post-conference-seminar-who-good-practices-desk-assessment-compliance-gmp-gcp-glp 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/2018-education-seminar-series-analysis-findings-gmp-inspections-pharmaceutical-manufacturers 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penyerahan-laporan-kajian-bioekuivalens-be-bagi-produk-produk-generik-berdaftar-dalam-bentuk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/iodinated-contrast-media-risk-severe-cutaneous-adverse-reactions-scar 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-publication-madrac-bulletin-issue-012018 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/stilnoxr-10-mg-film-coated-tablet-zolpidem-restriction-indication 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/domperidone-and-clarithromycin-drug-interaction-leading-increased-risk-qt-interval-prolongation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/noradrenaline-stress-cardiomyopathy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penipuan-kutipan-derma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/amoxicillin-containing-products-risk-drug-reaction-eosinophilia-and-systemic-symptoms-dress-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/carbocisteine-and-acetylcysteine-anaphylacticanaphylactoid-reactions-and-severe-cutaneous-adverse 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/drug-interaction-oral-contraceptives-containing-ethinylestradiol-direct-acting-antiviral 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mesalazine-risk-photosensitivity-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/methotrexate-pulmonary-alveolar-haemorrhage 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemetrexed-risk-nephrogenic-diabetes-insipidus-and-renal-tubular-necrosis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/propofol-and-sodium-valproate-risk-increased-propofol-blood-level-when-co-administered-valproate 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/efavirenz-risk-qtc-interval-prolongation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual-1 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/whats-new-npra-new-website 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/press-statement-director-general-health-cosmetic-products-found-contain-scheduled-poison 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/apixaban-drug-interaction-between-apixaban-and-selective-serotonin-reuptake-inhibitors-snri-andor 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azithromycin-clarithromycin-erythromycin-and-roxithromycin-risk-severe-cutaneous-adverse-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/saccharomyces-boulardii-risk-fungaemia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/isoniazid-risk-pancreatitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/montelukast-sodium-update-neuropsychiatric-adverse-reactions-obsessive-compulsive-symptoms 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/varenicline-tartrate-loss-consciousness 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/madrac-bulletin-issue-022018 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-jun-2018 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gmp-cosmetics-seminar 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/esmyar-ulipristal-acetate-new-contraindication-restricted-indication-and-liver-function-monitoring 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tecentriqr-atezolizumab-risk-nephritis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/eltrombopag-risk-interference-bilirubin-and-creatinine-test-results 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/succinylated-gelatin-modified-fluid-gelatin-possible-cross-reactions-involving-allergen-galactose 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tivicayr-dolutegravir-reports-neural-tube-defects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xgevar-denosumab-risk-new-primary-malignancy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/produk-baru-yang-diluluskan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/faq-quest-online-payment 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/membership-token 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/faq-quest-online-payment-soalan-lazim-pembayaran-atas-talian-quest 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pembukaan-data-editing-dan-penutupan-data-cleaning 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/jadual-pembukaan-section-s-revision-quest-3-untuk-tujuan-pelaksanaan-kawalan-regulatori-bahan-aktif 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gmp-cosmetics-seminar-0 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-ketua-pengarah-keihatan-kkm-produk-irbesartan-yang-ditarik-balik-di-amerika 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/online-payment-service-notice 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/produk-valsartan-dan-losartan-yang-ditarik-balik-di-amerika-syarikat-serta-situasi-di-pasaran 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-training-international-good-manufacturing-training-program-2019 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/verification-translated-official-documents 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/verifikasi-terjemahan-dokumen-rasmi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/27th-asean-consultative-committee-standards-and-quality 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/epilimr-sodium-valproate-important-new-restrictions-use 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/fluoroquinolones-risk-aortic-aneurysm-and-dissection 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/acetazolamide-new-contraindication-during-pregnancy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/beta-lactam-antibiotics-severe-cutaneous-adverse-reactions-scars 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ceftriaxone-disturbed-consciousness-convulsions-or-involuntary-movements 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/lamotrigine-risk-hemophagocytic-lymphohistiocytosis-hlh 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-disember-2018 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kementerian-kesihatan-malaysia-produk-tradisional-nan-bao-capsule-dikesan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penjualan-produk-herba-untuk-memulih-mencegah-demam-denggi 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tempoh-pembayaran-yang-belum-diselesaikan-pending-payment 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pending-payment-expiring-period 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direct-acting-antivirals-daavs-risk-hypoglycaemia-patients-diabetes 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/xylometazoline-increased-risk-serious-ventricular-arrhythmia-patients-long-qt-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-18-mac-2019-produk-tradisional-nan-bao-capsule-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/about-mygovxchange-online-payment-service-provided-mampu 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminder-implementation-regulatory-control-active-pharmaceutical-ingredients-api-registered-products 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/announcement-online-appeal-application-product-rejected-dca 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kpk-press-release-1-april-2019-cosmetic-products-found-contain-scheduled-poison 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kpk-press-release-29-january-2019-cosmetic-products-found-contain-scheduled-poison 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tapentadol-risk-seizures-and-reports-serotonin-syndrome-when-co-administered-other-drugs 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/oral-retinoids-risk-neuropsychiatric-symptoms 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/carbimazole-and-methimazole-thiamazole-i-risk-birth-defects-and-neonatal-disorders-case-exposure 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-5-april-2019-panggil-balik-ke-atas-produk-tradisional-mengandungi-paras-logam 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-29-mac-2019-produk-losartan-yang-ditarik-balik-di-singapura-serta-situasi-di 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/public-consultation-implementation-bioequivalence-be-study-requirements-new-drug-products-containing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-annex-1-requirements-active-pharmaceutical-ingredient-api-information-during-section-s 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-23-mei-2019-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/madrac-bulletin-012019-edition 2026-08-14T14:47:12+00:00 daily 0.9 https://npra-portal.demosistem.site/news/seminar-gmp-inspection-cell-and-gene-therapy-cgtp-facilities 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/benlystar-belimumab-increased-risk-serious-psychiatric-events 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/darzalex-daratumumab-new-identified-risk-hepatitis-b-virus-reactivation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/deferiprone-risk-neurological-disorders-children 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/posaconazole-pseudohyperaldosteronism 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tecentriqr-atezolizumab-new-important-identified-risk-immune-related-myositis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/imovaner-zopiclone-new-restriction-indication-and-additional-warnings-abuse-and-dependence 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/training-seminar-ich-stability-guidelines-ich-q1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-6-ogos-2019-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/permohonan-pembaharuan-lesen-pengilang-mengimport-pemborong-untuk-tahun-2020 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/manufacturers-importers-wholesalers-licence-renewal-application-year-2020 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/actemrar-tocilizumab-new-important-identified-risk-hepatotoxicity 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/diclofenac-systemic-use-i-risk-anastomotic-leakage-and-ii-risk-kounis-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminder-implementation-regulatory-control-active-pharmaceutical-ingredients-api-registered-products-0 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/lemtradar-alemtuzumab-i-risk-autoimmune-hepatitis-ii-other-serious-reactions-temporally-associated 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/clopidogrel-interaction-boosted-antiviral-human-immunodeficiency-virus-hiv-therapy-leading 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-2 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/online-registration-asean-accsq-tmhs-pwg-2019 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-30-sept-2019-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-guidance-notes-api-information-product-registration-version-30-october-2019 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-20-sept-2019-penilaian-semula-produk-berdaftar-yang-mengandungi-bahan-aktif 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-april-2019 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/smectar-dioctahedral-smectite-not-recommended-use-children-aged-below-2-years-and-pregnant-or 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-terkini-berkaitan-penilaian-semula-produk-berdaftar-yang-mengandungi-bahan-aktif-ranitidine 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/laporan-tahunan-npra-2018 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-annual-report-2018 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/news/soalan-soalan-lazim-faq-impuriti-ndma-di-dalam-produk-ranitidine 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengilang-tradisional-suplemen-kesihatan-dan-kosmetiktindakan-regulatori-kerana-kegagalan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengilang-farmaseutikal-radiofarmaseutikal-dan-veterinarpembayaran-fi-pemeriksaan-apb-secara-pra 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/berita-ubat-ubatan-september-2019 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pharmaceutical-radiopharmaceutical-veterinary-products-manufacturer-prepaid-gmp-inspection-fees 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/traditional-health-supplement-cosmetics-manufacturer-regulatory-act-upon-manufacturer-unpaid-gmp 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/feburicr-febuxostat-increased-risk-cardiovascular-death-and-all-cause-mortality-patients-treated 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/retinoids-updated-measures-pregnancy-prevention-during-retinoids-use 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hsa-npra-generic-medicines-work-sharing-initiative 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-guidance-notes-api-information-product-registration-version-40-december-2019 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-terkini-status-produk-ranitidine-berkaitan-impuriti-n-nitrosodimethylamine-ndma 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-5-disember-2019-isu-panggil-balik-tiga-produk-metformin-daripada-pasaran 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/change-administrative-procedure-section-s-revision-registered-products-non-anti-infectives 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-24-disember-2019-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-safety-measure-sodium-valproate-i-risk-congenital-malformation-neonates-and-neurodevelopmental 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklumat-terkini-status-produk-ranitidine-berkaitan-impuriti-n-nitrosodimethylamine-ndma-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/part-2-npra-regulatory-updates-2019-2020 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cyclin-dependent-kinase-46-cdk-46-inhibitors-risk-severe-lung-inflammation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ondansetron-birth-defects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sulfasalazine-interference-dihydronicotinamide-adenine-dinucleotide-dihydronicotinamide-adenine 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notifikasi-pengaktifan-fungsi-pengimbasan-pointer-ptr-record-dan-sender-policy-framework-spf-record 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/perlaksanaan-perintah-kawalan-pergerakan-di-premis-npra-implementation-movement-control-order-npra 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/madrac-bulletin-032019-edition 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/esbrietr-pirfenidone-drug-induced-liver-injury-dili 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kyprolir-carfilzomib-i-risk-progressive-multifocal-leukoencephalopathy-pml-ii-risk-hepatitis-b-virus 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/nivolumab-reports-cytomegalovirus-cmv-infection-or-reactivation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/intravenous-iron-containing-products-kounis-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/esmya-ulipristal-acetate-5-mg-product-recall-due-potential-risk-liver-injury 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/guselkumab-risk-anaphylaxis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-25-april-2020-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/nintedanib-ischaemic-colitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rocuronium-kounis-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gabapentin-risk-dysphagia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/proton-pump-inhibitors-risk-microscopic-colitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/domperidone-restriction-use-paediatric-patients-less-12-years-age 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-9-jun-2020-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-mopi-training-virtual-good-manufacturing-training-program-2020 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-guidance-notes-api-information-product-registration-version-50-june-2020 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pusat-pengambilan-permit-sijil-lesen-setempat-di-npra 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminder-risk-oculogyric-crisis-metoclopramide-use 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pekeliling-berkenaan-pengemaskinian-miv-n-do-tell-untuk-produk-farmaseutikal-suplemen-kesihatan-dan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-15-julai-2020-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/e-engagement-session-phases-implementation-routine-good-distribution-practice-gdp-inspection 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sesi-e-engagement-pelaksanaan-pelan-berfasa-pemeriksaan-amalan-pengedaran-baik-aeb-secara-rutin-ke 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/online-public-engagement 2026-08-13T12:56:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/insulin-risk-cutaneous-amyloidosis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/topiramate-risk-uveitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/plaquenilr-hydroxycholoroquine-risk-qt-prolongation-and-other-drug-drug-interactions-context-covid 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/propofol-risk-priapism 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/parenteral-nutrition-containing-amino-acids-andor-lipids-risk-toxic-degradations-ingredients-when 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/gilenyar-fingolimod-new-contraindication-pregnant-women-and-women-childbearing-potential-who-are-not 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/guidelines-conditional-registration-new-chemical-entities-and-biologics-2nd-edition 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-23-oktober-2020-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pekeliling-berkenaan-keperluan-pengujian-impuriti-nitrosamine-bagi-produk-yang-mengandungi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/esmya-ulipristal-acetate-5-mg-withdrawal-product-registration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-updates-reports-kidney-related-and-liver-related-adverse-reactions-after-consumption-ganoderma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maintenance-payment-quest3 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-training-virtual-good-manufacturing-training-program-2021 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tumour-necrosis-factor-alpha-tnfa-kaposis-sarcoma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/lemtradar-alemtuzumab-revised-indication-additional-contraindications-and-risk-minimisation-measures 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ondansetron-information-updates-risk-birth-defects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-kosmetik-dikesan-mengandungi-racun-berjadual-januari-2021 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/abiraterone-risk-hypoglycaemia-due-drug-interaction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/clozapine-risk-serious-bowel-complications-caused-constipation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/oseltamivir-thrombocytopenia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mesalazine-and-sulfasalazine-nephrolithiasis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/efavirenz-including-combination-products-risk-late-onset-neurotoxicity 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-january-2021 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-pengukuhan-pelaksanaan-kawalan-regulatori-ke-atas-produk-produk-gas-perubatan-dan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pekeliling-berkenaan-pelaksanaan-prosedur-kerja-penilaian-desktop-bagi-aktiviti-pemeriksaan-amalan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-updates-covid-19-vaccine-comirnatyr 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-pihak-berkuasa-kawalan-dadah-pbkd-berkenaan-pengecualian-daripada-keperluan-menjalankan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-10-mac-2021-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-6-april-2021-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-pendaftaran-bersyarat-secara-recognition-berdasarkan-who-emergency-use-listing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-vascular-endothelial-growth-factor-vegf-inhibitors 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-rocuronium-pengemaskinian-sisip-bungkusan-dengan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-mengandungi-mirtazapine-pengemaskinian-sisip-bungkusan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ceftriaxone-risk-encephalopathy 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mirtazapine-risks-i-amnesia-and-ii-drug-reaction-eosinophilia-and-systemic-symptoms-dress 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/vascular-endothelial-growth-factor-vegf-inhibitors-systemic-use-except-application-eyes-risk-artery 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tecentriqr-atezolizumab-risk-severe-cutaneous-adverse-reactions-scars 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/antidepressants-citalopram-desvenlafaxine-escitalopram-fluoxetine-fluvoxamine-paroxetine-sertraline 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-pelaksanaan-aktiviti-lot-release-ke-atas-produk-vaksin-dan-produk-plasma-yang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-4-mei-2021-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-annual-report-2020 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/garis-panduan-pengiktirafan-makmal-swasta-oleh-bahagian-regulatori-farmasi-negara-npra-bagi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/awareness-and-training-quality-control-herbal-raw-materials-natural-product-manufacturing 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-11-jun-2021-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-ceftriaxone-pengemaskinian-sisip-bungkusan-dengan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/oseltamivir-risk-haemorrhages 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/senarai-produk-tidak-berdaftarberdaftar-tetapi-tidak-dipasarkan-yang-diperlukan-untuk-rawatan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-first-revision-july 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mycophenolate-mofetil-mmf-and-myocophenolic-acid-mpa-risk-de-novo-purine-synthesis-inhibitors 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-kosmetik-dikesan-mengandungi-racun-berjadual-ogos-2021 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemeriksaan-amalan-perkilangan-baik-apb-dalam-dan-luar-negara-oleh-bahagian-regulatori-farmasi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pekeliling-berkenaan-pengeluaran-dua-2-garis-panduan-farmakovigilans 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sacubitrilvalsartan-risk-psychiatric-events 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/awareness-quality-control-testing-herbal-raw-materials-natural-product-workshop 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invitation-becoming-npras-panel-labs 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/voluntary-registration-surface-disinfectants 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-kosmetik-dikesan-mengandungi-racun-berjadual-17-september-2021 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pre-submission-meeting-psm-guidance-document 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/permit-certificate-licence-collection-hub 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notice-update-enquiry-complaint-form 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/non-vitamin-k-antagonist-oral-anticoagulants-noacs-risk-abnormal-uterine-bleeding 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-npra-financial-year-end-closure-2021 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/bortezomib-risk-guillain-barre-syndrome-and-demyelinating-polyneuropathy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-insulin-termasuk-produk-kombinasi-pengemaskinian-sisip 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-mycophenolate-mycophenolate-mofetil-dan-mycophenolic 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-bortezomib-pengemaskinian-sisip-bungkusan-dengan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-semua-produk-yang-mengandungi-anastrozole-pengemaskinian-sisip-bungkusan-dan-risalah 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-kosmetik-dikesan-mengandungi-racun-berjadual-21-oktober-2021 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-starts-today 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-always-reportsideeffects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-keperluan-mendaftar-penyelidikan-klinikal-sukarelawan-sihat-dengan-national 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-keperluan-mendaftar-penyelidikan-klinikal-sukarelawan-sihat-dengan-national-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-working-together-we-can-make-vaccines-better-everyone 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-berkenaan-keperluan-mendaftar-penyelidikan-klinikal-sukarelawan-sihat-dengan-national-1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-16-nov-2021-pemanjangan-jangka-hayat-produk-vaksin-jenis-coronavac-dan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pembatalan-arahan-bilangan-26-tahun-2017-direktif-pindaan-had-harian-pengambilan-menthol-dalam 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/natural-products-pre-registration-test 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/anastrozole-risk-depression 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penolakan-kajian-bioekuivalens-be-yang-dijalankan-oleh-pusat-kajian-be-synchron-research-services 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rejection-bioequivalence-be-studies-conducted-be-centres-synchron-research-services-and-panexcell 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/decitabine-risk-differentiation-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-menerima-permohonan-kebenaran-mengilang-produk-tidak-berdaftar-untuk-tujuan-percubaan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/issues-accessing-quest3-avast-antivirus 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sulfamethoxazole-trimethoprim-co-trimoxazole-risk-acute-respiratory-distress-syndrome-ards 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/clindamycin-risk-acute-renal-failure 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/janus-kinase-jak-inhibitors-rheumatoid-arthritis-patients-risk-major-adverse-cardiovascular-events 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/janus-kinase-jak-inhibitors-rheumatoid-arthritis-patients-risk-major-adverse-cardiovascular-events-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-pengarah-npra-4-januari-2022-maklum-balas-berkenaan-laporan-kesan-advers-susulan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-training-virtual-good-manufacturing-training-program-2022 2026-08-12T14:46:26+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-8-januari-2022-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-third-edition-second-revision 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-customer-satisfaction-survey-2022 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kajian-kepuasan-pelanggan-npra-tahun-2022 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rejection-be-studies-conducted-be-centre-micro-therapeutic-labs-following-inspection-findings 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/additional-indications-approved-2 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-16-februari-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-23-februari-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/regulatory-control-medicinal-gases 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-bahagian-regulatori-farmasi-negara-kkm-status-laporan-kesan-advers-susulan-imunisasi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-9-mac-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-16-mac-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/tenofovir-alafenamide-risk-renal-adverse-effects 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-24-mac-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/voluntary-good-pharmacovigilance-practices-gvp-inspection-pharmaceutical-product-registration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-30-mac-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-produk-kosmetik-dikesan-mengandungi-racun-berjadual-1-april-2022 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/betamethasone-systemic-risk-pheochromocytoma-crisis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-6-april-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi-vaksin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-13-april-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/refund-procedure-involving-online-payment-made-national-pharmaceutical-regulatory-agency-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/prosedur-tuntutan-bayaran-balik-melibatkan-pembayaran-atas-talian-sistem-quest3-di-bahagian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-27-april-2022-status-laporan-kesan-advers-susulan-imunisasi-aefi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hydrochlorothiazide-chlorthalidone-indapamide-and-acetazolamide-risk-choroidal-effusion-acute-myopia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/warfarin-risk-anticoagulant-related-nephropathy-arn 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-28-april-2022-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-updates-covid-19-vaccines-risk-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cold-chain-facilities-list 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/perlaksanaan-pemeriksaan-regulatori-dalam-dan-luar-negara-secara-lapangan-site-oleh-bahagian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mavencladr-cladribine-risk-serious-liver-injury-and-new-recommendations-about-liver-function 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azathioprine-risk-erythema-nodosum 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-permohonan-pertukaran-masuk-pegawai-farmasi-kkm-ke-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/olmesartan-risk-autoimmune-hepatitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/empagliflozin-risk-tubulointerstitial-nephritis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/loperamide-risk-acute-pancreatitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-4-julai-2022-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pekeliling-berkenaan-pengemaskinian-garis-panduan-malaysian-variation-guideline-pharmaceutical 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/chloroquine-and-hydroxychloroquine-risk-psychiatric-disorders 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/corticosteroids-systemic-risk-pheochromocytoma-crisis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-guidance-notes-active-pharmaceutical-ingredients-api-information-product-registration-version 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/anugerah-pekerja-cemerlang-bulanan-bahagian-regulatori-farmasi-negara-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengemaskinian-tempoh-jangka-hayat-vaksin-covid-19-comirnaty-coronavac 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/senarai-produk-tidak-berdaftarberdaftar-tetapi-tidak-dipasarkan-dengan-bilangan-permohonan-ubat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-23-ogos-2022-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penarikan-balik-syarat-pendaftaran-khas-bagi-vaksin-covid-19-hanya-boleh-dijual-atau-dibekal-kepada 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-14-september-2022-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/metformin-risk-vitamin-b12-deficiency 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/publication-revised-pics-annex-1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/alecensar-alectinib-risk-haemolytic-anaemia-new-warning-and-precaution-and-dose-modification 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/brolucizumab-pagenaxr-risk-intraocular-inflammation-including-retinal-vasculitis-andor-retinal 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/nirmatrelvir-ritonavir-paxlovid-risk-anaphylaxis-and-hypersensitivity-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sertraline-risk-microscopic-colitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/labetalol-risk-nipple-pain-and-raynauds-phenomenon-nipple 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-updates-covid-19-vaccines-risk-tinnitus 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-23-oktober-2022-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengemaskinian-tempoh-jangka-hayat-antiviral-covid-19-iaitu-paxlovid-daripada-12-bulan-kepada-18 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/iodinated-contrast-media-risk-hypothyroidism-particularly-newborns-and-young-children 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/piperacillin-risk-haemophagocytic-lymphohistiocytosis-hlh 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penutupan-akhir-tahun-kewangan-npra-2022 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/methadone-risk-hypoglycaemia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/get-ready-medsafetyweek 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-starts-today-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/temporary-solution-java-security-login-problem 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/why-do-we-monitor-safety-medicines 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/how-can-you-help-us-making-medicines-safer-everyone 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/have-you-ever-experienced-side-effect-medicine 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/when-you-report-suspected-side-effect-medicine-we-learn-more-about-it 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-7-november-2022-pelancaran-minggu-keselamatan-ubat-medsafetyweek-2022 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hey-are-you-pharmacist 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/how-medication-safety-works 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/thank-you-joining-medsafetyweek 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengemaskinian-tempoh-jangka-hayat-vaksin-comirnaty-adult-dose-daripada-12-bulan-kepada-15-bulan 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/laporan-kajian-kepuasan-pelanggan-luar-npra-tahun-2022 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-training-virtual-good-manufacturing-training-program-2023 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hydroxychloroquine-and-chloroquine-risk-hepatic-impairment 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sorafenib-risk-thrombotic-microangiopathy-tma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-pengemaskinian-tempoh-jangka-hayat-antiviral-covid-19-iaitu-lagevrio-200mg-hard-capsule 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pneumococcal-polysaccharide-vaccine-23-valent-extensive-swelling-vaccinated-limb 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/bioequivalence-ethics-committee-section-activities-2022-glance 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-4-januari-2023-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-permohonan-pertukaran-masuk-pegawai-farmasi-kkm-ke-npra-kemaskini-10012023 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/donepezil-risk-qt-prolongation-and-torsade-de-pointes 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/maklum-balas-bahagian-regulatori-farmasi-negara-npra-berhubung-artikel-berkaitan-rawatan-covid-19 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-13-februari-2023-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/change-venue-national-regulatory-conference-nrc-2023-m-resort-hotel-kuala-lumpur 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-pertukaran-tempat-penganjuran-national-regulatory-conference-nrc-2023-ke-m-resort-hotel 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-pholcodine-risk-anaphylaxis-neuromuscular-blocking-agents-nmbas 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/declaration-worldwide-registration-status-generic-medicines-quest-system 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengisytiharan-status-pendaftaran-produk-di-negara-lain-untuk-ubat-generik-dalam-sistem-quest 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-topiramate-neurodevelopmental-disorders-children-exposed-topiramate-during-pregnancy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-22-mac-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-customer-satisfaction-survey 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kajian-kepuasan-pelanggan-npra 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/analysis-deficiencies-observed-during-site-good-manufacturing-practice-gmp-inspections-local-and 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/label-use-diclofenac-suppositories-treat-fever-children-potential-risk-acute-necrotising 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invitation-seminar-ispe-malaysia-education-series-strengthening-gdp-fundamentals 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pengemaskinian-tempoh-jangka-hayat-antiviral-covid-19-iaitu-paxlovid-daripada-18-bulan-kepada-24 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azacitidine-risk-differentiation-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/comirnaty-vaccine-risk-heavy-menstrual-bleeding 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/griseofulvin-risk-severe-cutaneous-adverse-reactions-scars 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-25-mei-2023-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/glypressinr-terlipressin-serious-or-fatal-respiratory-failure-and-sepsisseptic-shock-patients-type-1 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-23-mac-2023-pembatalan-pendaftaran-dan-panggil-balik-bagi-semua-produk-yang 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-pengemaskinian-tempoh-jangka-hayat-antiviral-covid-19-iaitu-evusheld-daripada-18-bulan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-12-julai-2023-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-10-julai-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-8-julai-2023-keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-386 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/statins-risk-inducing-or-aggravating-myasthenia-gravis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/third-generation-aromatase-inhibitors-anastrozole-exemestane-letrozole-risk-tendon-disorders 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-penamatan-aktiviti-pemantauan-dan-pengemaskinian-rekod-paras-stok-produk-berdaftar 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-pengemaskinian-tempoh-jangka-hayat-vaksin-covid-19-iaitu-coronavac-daripada-30-bulan-kepada 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/screening-checklist-generic-medicines-prescription-full 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-penggunaan-screening-checklist-untuk-produk-generik-prescription-full 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-pengemaskinian-tempoh-jangka-hayat-vaksin-covid-19-iaitu-comirnaty-kepada-24-bulan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-clindamycin-systemic-risk-acute-kidney-injury 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/valaciclovir-risk-drug-reaction-eosinophilia-and-systemic-symptoms-dress 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-21-ogos-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/npra-updates-reports-kidney-related-adverse-reactions-after-consumption-oral-aloe-vera-containing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cephalosporins-risk-seizures 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-15-september-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/isotretinoin-risk-psychiatric-disorders-and-sexual-dysfunction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-24-okt-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/get-ready-medsafetyweek-2023 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/preparations-medsafetyweek-are-well-underway-are-you-ready 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-kicks-today 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/unexpected-side-effects-can-happen-anywhere-any-time-your-report-patients-safety 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medications-malaysia-are-continually-monitored-ensure-their-safety 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/concerned-about-side-effects-remember-check-talk-and-tell-medsafetyweek 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sleep-troubles-after-medication-remember-report-them 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hey-are-you-doctor 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hi-are-you-nurse 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hello-are-you-pharmacist 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/thanks-joining-medsafetyweek-2023 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-388-berkenaan-kelulusan-pendaftaran-pertama 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-loperamide-risk-acute-pancreatitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/imbruvicaribrutinib-package-insert-updates-dose-modifications-adverse-reactions-and-special-warnings 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/clomiphene-risk-serious-visual-disturbances-potentially-leading-blindness 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invitation-seminar-ispe-online-gdp-seminar-module-1-qms-documentation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-6-disember-2023-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rivastigmine-risks-qt-prolongation-and-torsade-de-pointes 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/imatinib-risk-thrombotic-microangiopathy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/penolakan-kajian-bioekuivalens-be-yang-dijalankan-oleh-pusat-kajian-be-synapse-labs-pvt-ltd-susulan 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rejection-be-studies-conducted-be-centre-synapse-labs-pvt-ltd-india-following-inspection-findings 2026-08-12T15:14:51+00:00 daily 0.9 https://npra-portal.demosistem.site/news/laporan-kajian-kepuasan-pelanggan-luar-npra-tahun-2023 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/bioequivalence-ethics-committee-section-activities-2023-glance-and-more 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/statins-atorvastatin-rosuvastatin-simvastatin-interaction-ticagrelor-leading-increased-risk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-393 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-380-berkenaan-pendaftaran-vaksin-covid-19 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-381-berkenaan-pendaftaran-produk-ubat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/keputusan-mesyuarat-pihak-berkuasa-kawalan-dadah-kali-ke-383-berkenaan-produk-orphan-medicine 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-metformin-risk-vitamin-b12-deficiency 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/domperidone-risk-psychiatric-withdrawal-events-when-used-label-lactation-stimulation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-akhbar-kpk-19-mac-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/information-sharing-paper-cosmetic-products-37th-asean-cosmetic-committee-meeting-8-9th-may-2023 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-npra-1-april-2024-status-suplemen-kesihatan-beni-koji-choleste-help 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-penambahbaikan-proses-pengeluaran-lesen-mengimport-lesen-pemborong-melalui-penilaian-dan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/invitation-seminar-ispe-online-gdp-seminar-module-2-validation-self-inspection-requirement-gdp 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/closed-public-consultation-malaysian-guideline-bioequivalence-inspection-2nd-edition 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-kanan-perkhidmatan-farmasi-6-april-2024-keputusan-mesyuarat-pihak-berkuasa 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-pengarah-kanan-perkhidmatan-farmasi-5-april-2024-keputusan-mesyuarat-pihak-berkuasa 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ciprofloxacin-moxifloxacin-levofloxacin-and-ofloxacin-fluoroquinolones-systemic-use-oral-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hydrochlorothiazide-risk-acute-respiratory-distress-syndrome-ards 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-22-april-2024-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/levetiracetam-and-clobazam-drug-reaction-eosinophilia-and-systemic-symptoms-dress 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/proton-pump-inhibitors-risk-erectile-dysfunction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-olmesartan-risk-autoimmune-hepatitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/revision-timelines-variation-applications-registered-products-pharmaceutical-products-natural-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kementerian-kesihatan-malaysia-majlis-menandatangani-semula-memorandum-persefahaman 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sodium-glucose-co-transporter-2-sglt2-inhibitors-dapagliflozin-empagliflozin-canagliflozin 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/amoxicillin-risk-aseptic-meningitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-29-mei-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/registration-application-submitted-facilitated-registration-pathway-frp-faqs 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/anti-clusters-differentiation-20-cd20-antibodies-rituximab-obinutuzumab-ofatumumab-ocrelizumab-risk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kpk-9-julai-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hydroxychloroquine-risk-sweets-syndrome-acute-febrile-neutrophilic-dermatosis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pre-membership-module-announcement 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/17-hydroxyprogesterone-caproate-17-ohpc-potential-cancer-risk-offspring-exposed-utero-and-limited 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/deficiency-analysis-site-good-manufacturing-practice-gmp-inspections-manufacturers-medicinal 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-5-ogos-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-14T10:04:16+00:00 daily 0.9 https://npra-portal.demosistem.site/news/announcement-product-registration-holders-prhs-revision-categories-and-criteria-newadditional 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azacitidine-injectable-formulation-risk-cutaneous-vasculitis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/progestogens-cyproterone-acetate-medroxyprogesterone-acetate-chlormadinone-risk-meningioma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notis-makluman-urusan-pembayaran-bank-draf-atau-kiriman-wang-bagi-permohonan-pemeriksaan-pusat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-signal-alert-mefenamic-acid-associated-generalised-bullous-fixed-drug-eruption-gbfde 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-kawalan-kualiti-ke-atas-bahan-mentah-herba-dan-produk-semula-jadi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/paracetamol-and-fixed-drug-eruption-fde-upward-trend-reports-involving-paediatric-patients 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/fluconazole-updates-known-risk-spontaneous-abortion-during-pregnancy-and-congenital-malformations 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pseudoephedrine-risk-posterior-reversible-encephalopathy-syndrome-pres-and-reversible-cerebral 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-30-september-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-02-oktober-2024-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-17-hydroxyprogesterone-caproate-17-ohpc-cancellation-product-registration-and-product-recall 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kementerian-kesihatan-malaysia-8-oktober-2024-kelulusan-pendaftaran-bagi-produk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/good-submission-practice-20-generic-medicines 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/join-us-next-week-medsafetyweek 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/were-ready-medsafetyweek-are-you 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-starts-today-1 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/prevent-side-effects-taking-medicines-right-way 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sesi-libat-urus-antara-bahagian-regulatori-farmasi-negara-npra-bersama-pihak-berkepentingan 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/not-all-medicines-are-suitable-everyone 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/not-all-medicines-are-equal 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kementerian-kesihatan-malaysia-pelancaran-minggu-keselamatan-ubat-medsafetyweek-2024 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/5questions-ask-your-healthcare-professional-help-prevent-side-effects 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/5questions-ask-your-patients-help-prevent-side-effects 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medicines-are-continually-monitored-ensure-their-safety 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/thanks-joining-medsafetyweek 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mopi-quality-assurance-and-gmp-training-program-2026 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-pelaksanaan-pemeriksaan-amalan-pengedaran-baik-aeb-secara-jarak-jauh 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/ethambutol-risk-drug-reaction-eosinophilia-and-systemic-symptoms-dress 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-17-januari-2025-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-glucagon-peptide-1-glp-1-receptor-agonists-dulaglutide-liraglutide-lixisenatide-semaglutide 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-5-februari-2025-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/hydroxychloroquine-small-increased-risk-major-congenital-malformations-children-following-utero 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/submission-rimup-evaluation-pharmacovigilance-section-pkkk 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/outcome-gvp-inspection-voluntary-phase-2023-2024-preliminary-key-findings-trends 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azithromycin-rare-risk-cardiovascular-death 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/senarai-produk-tidak-berdaftarberdaftar-tetapi-tidak-dipasarkan-dengan-bilangan-permohonan-ubat-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-15-mei-2025-makluman-produk-produk-kosmetik-yang-dikesan-mengandungi-racun 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-15-mei-2025-makluman-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/azathioprine-risk-non-cirrhotic-portal-hypertension-ncph-portosinusoidal-vascular-disease-pvsd 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/enoxaparin-risk-acute-generalised-exanthematous-pustulosis-agep 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/guidance-document-verification-traditional-medicines-tm-health-supplements-hs-manufacturers-second 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/isotretinoin-risk-sacroiliitis-and-urethritis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-statins-risk-inducing-or-aggravating-myasthenia-gravis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/angiotensin-ii-receptor-blockers-arbs-risk-intestinal-angioedema 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/screening-package-new-drug-products-and-biologics 2026-08-12T14:58:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/reminder-submission-rimup-evaluation-pharmacovigilance-section-single-variation-only 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/rituximab-risks-enteroviral-meningoencephalitis-and-false-negative-serologic-testing-infections 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/surveillance-and-complaints-section-highlights-2024 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/valproate-sodium-valproate-valproic-acid-potential-risks-offspring-following-paternal-exposure-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/bengkel-pengujian-kawalan-kualiti-bahan-mentah-herba-bagi-produk-semulajadi 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-18-ogos-2025-makluman-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-18-ogos-2025-makluman-produk-tradisional-berdaftar-mengandungi-paras-merkuri 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/oral-anticoagulants-apixaban-dabigatran-edoxaban-rivaroxaban-and-warfarin-risk-atraumatic-splenic 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-sangkutan-prp-di-npra-2025 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-signal-alert-lamotrigine-erythema-multiforme-em 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-progestogens-cyproterone-acetate-medroxyprogesterone-acetate-chlormadinone-risk-meningioma 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-hydroxychloroquine-1-small-increased-risk-major-congenital-malformations-children-following 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/news/finasteride-and-dutasteride-risk-suicidal-thoughts 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/coming-soon-medsafetyweek-2025 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/safety-signal-alert-doxycycline-fixed-drug-eruption-fde 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/jom-sertai-majlis-pelancaran-medsafetyweek-2025 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-almost-here-are-you-ready 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-2025-starts-today 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/we-all-have-power-be-medsafetyhero 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/do-you-know-how-be-medsafetyhero 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medicines-safety-starts-you-and-me 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/4-ways-patients-can-be-medsafetyheroes 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/4-ways-healthcare-professionals-can-be-medsafetyheroes 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/monitoring-safety-medicines-doesnt-stop-once-they-hit-pharmacy-shelves 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/thats-wrap-years-medsafetyweek-campaign 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/medsafetyweek-turns-10 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/siaran-media-kementerian-kesihatan-malaysia-pelancaran-minggu-keselamatan-ubat-medsafetyweek-2025 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pemakluman-pemulihan-sistem-quest3 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/amiodarone-risk-primary-graft-dysfunction-after-heart-transplantation 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/updated-sulfamethoxazole-trimethoprim-cotrimoxazole-risk-circulatory-shock 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/selective-serotonin-reuptake-inhibitors-ssris-and-serotonin-norepinephrine-reuptake-inhibitors-snris 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cyclin-dependent-kinase-inhibitors-cdkis-interaction-statins-leading-potential-risk-rhabdomyolysis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-8-november-2025-makluman-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/makluman-penutupan-pembayaran-akhir-tahun-2025 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/linezolid-risk-rhabdomyolysis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/notis-pembersihan-data-produk-berstatus-saved-form-expired-dalam-sistem-quest-3 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-3-disember-2025-makluman-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/prescription-opioid-risk-oesophageal-dysfunction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/garcinia-cambogia-and-hydroxycitric-acid-risk-hepatotoxicity 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/vitamin-b6-pyridoxine-risk-peripheral-neuropathy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/palbociclib-risk-venous-thromboembolism 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/official-announcement-national-regulatory-conference-2026 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-9-februari-2026-makluman-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/denosumab-proliar-and-biosimilars-multi-vertebral-fractures-mvf-after-discontinuation-denosumab 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cellceptr-mycophenolate-mofetil-new-important-identified-risk-anaphylactic-reaction 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/plaquenilr-hydroxychloroquine-potential-risk-major-congenital-malformations-and-new-risks 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/latihan-sangkutan-di-npra-bagi-latihan-liberalisasi-ahli-farmasi-provisional-prp-di-bawah-bahagian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/kenyataan-media-kkm-2-april-2026-makluman-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-analytical-testing-and-labelling-declaration-requirements-products-containing-animal-derived 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/update-borang-permohonan-sijil-indikasi-sijil-deklarasi-bagi-produk-berdaftar-dengan-pihak-berkuasa 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/official-launch-npra-gcp-glp-be-ec-inspection-dashboard 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/sunitinib-risk-hyperammonaemic-encephalopathy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/moxifloxacin-drug-reaction-eosinophilia-and-systemic-symptoms-dress-fixed-drug-eruption-fde-and 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/mesalazine-risk-idiopathic-intracranial-hypertension-iih 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/clindamycin-hydrochloride-oral-capsules-risk-oesophagitis-and-oesophageal-ulcer 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/columvir-glofitamab-new-important-identified-risk-haemophagocytic-lymphohistiocytosis 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/polivyr-polatuzumab-vedotin-identified-risk-severe-infusion-site-extravasation-events 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/pelaksanaan-kajian-kepuasan-pelanggan-luaran-program-perkhidmatan-farmasi-kkm 2026-09-11T08:29:02+00:00 daily 0.9 https://npra-portal.demosistem.site/news/aciclovir-oralinjectable-and-valaciclovir-risk-acute-generalised-exanthematous-pustulosis-agep 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/cefazolin-risk-kounis-syndrome 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/lamotrigine-risk-photosensitivity-reactions 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/new-login-method-quest3-system-mytrustid 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/news/test-news 2026-09-17T10:30:53+00:00 daily 0.9 https://npra-portal.demosistem.site/terms-service 2026-07-30T09:44:02+00:00 daily 0.9 https://npra-portal.demosistem.site/tahap-pencapaian-perkhidmatan-tahun-terkini 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/regulatory-guidelines 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/licensing-manufacturer-importer-and-wholesaler 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-reporting-healthcare-professionals 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-reporting-consumers 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-reporting-product-registration-holders 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-licensing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-cosmetic 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-veterinary 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-active-pharmaceutical-ingredient-api 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-product-registration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/product-recall 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/disclaimer 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/privacy 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/research-project-collaboration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faqs 2026-08-15T02:00:46+00:00 daily 0.9 https://npra-portal.demosistem.site/good-laboratory-practice 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/digital-certificate 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/product-cancellation 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/client-charter 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/c-security 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/b-online-system 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/quest3-system 2026-08-15T00:45:04+00:00 daily 0.9 https://npra-portal.demosistem.site/online-payment-quest3 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/borang-kemaskini-laman-web-online-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/conditional-registration-dengue-vaccine-use-malaysians-9-45-years-age 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/workflow-manual-registration-export-only-feo-products 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/4-easy-steps-online-payment-quest3-system-payment-credit-card 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/latar-belakang-dan-pengenalan-sistem-quest 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/4-easy-steps-online-payment-quest3-system-payment-credit-card-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/latar-belakang-dan-pengenalan-sistem-quest-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/biowaiver-considerations-based-unavailabilityinaccessibility-comparator-product-and-other 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/user-registration-process-quest3-products-registration-licensing-system 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/purpose-registration-generic-products-prh-shall-provide-patent-declarations-below-i-prh-shall-comply 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/42-withdrawal-product-registration 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/credit-card-online-payment-quest3-system 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/variation-application-pharmaceutical-products-malaysian-variation-guideline-mvg 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-11-12-13-product-name 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-21-26-dosage-form 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/user-registration-process-quest3-products-registration-licensing-system-proses-pendaftaran-keahlian 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-31-38-active-ingredients 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-41-45-excipients 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/registration-product-export-only-feo 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/a4-product-description 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/appendix-7-special-conditions-registration-particular-product-or-group-products 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/appendix-14-guidelines-safety-data-requirements-complementary-medicine-products 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-product-formula 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-particular-packing 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/10-guideline-submission-analytical-method-validation-amv-documents 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/6-notification-withdrawal 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/7-notification-exemption 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/8-certificate-free-sale 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/appendix-14-guidelines-safety-data-requirements-complementary-medicine-products-0 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/fungsi-dan-peranan 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/main-menu-information-maklumat 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/visi-misi-dan-objektif 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pengiktirafan-dan-anugerah-yang-diterima-npra 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pics-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/menu-untuk-pengguna 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/anggota-pbkd 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pengenalan-madrac 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/ahli-madrac 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/senarai-pengilang-kosmetik-di-sistem-quest 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/penjualan-produk-herba-untuk-memulih-mencegah-demam-denggi 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/achievement-npras-clients-charter-year-2016-january-december 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/pencapaian-piagam-pelanggan-npra-untuk-tahun-2016-januari-disember 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/kenyataan-akhbar-kpk-23-mei-2019-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/dasar-privasi-npra-product-status 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-pharmacovigilance 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/q-hand-sanitizer 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/national-working-committee-bioequivalence-be-study 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/roles-function-2 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/revised-application-forms-effective-15-july-2022 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/panduan-membuat-banner-home-website-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/iklan-sebut-harga-kerja-kerja-menaiktaraf-sistem-pendingin-hawa-di-program-perkhidmatan-farmasi-ibu 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/12th-national-pharmacy-rd-conference-19-21-august-2024 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/borang-permohonan-atas-talian-untuk-kakitangan-npra 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/announcement-product-registration-holders-prhs-pilot-project-post-approval-changes-variation-using 2026-08-10T06:31:54+00:00 daily 0.9 https://npra-portal.demosistem.site/ahli-madrac-0 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/frequently-asked-questions-faqs-appendix-19-general-labelling-requirement-products-containing-animal 2026-08-10T06:31:54+00:00 daily 0.9 https://npra-portal.demosistem.site/revised-application-forms-effective-2-january-2025 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/panel-experts-poe-clinical-trial-import-licence-ctil-and-clinical-trial-exemption-ctx 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/frequently-asked-question-faq-use-chloroform-product-formulation-following-directive-issued-19th 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/bioequivalence-ethics-committee-section-activities-2024-key-activities-and-performance 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/alecensar-alectinib-guidance-management-severe-hypertriglyceridaemia 2026-08-12T15:11:44+00:00 daily 0.9 https://npra-portal.demosistem.site/home-0 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/cancellation-complementary-alternative-products 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/online-public-engagement 2026-08-15T01:35:55+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-product-registration-0 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/conditions-pertaining-patent 2026-08-14T11:39:32+00:00 daily 0.9 https://npra-portal.demosistem.site/product-registration-process-prescription 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/laboratory-quality-control 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-generic-product-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-generic-medicine 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-generic 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-generic 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-generic 2026-08-18T05:20:43+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-generic 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-generic 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-generic 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-generic 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-generic 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-generic 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-generic 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-generic 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-generic 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/komplian-dan-pelesenan 2026-08-18T05:20:43+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-generic-medicine 2026-08-10T18:10:08+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-generic-medicine 2026-08-18T05:23:31+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-generic 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-laboratory 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-licensing-0 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-api 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/buletin-madrac 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-natural-products 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-natural-product-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-natural-products 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-natural-product 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-natural-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-natural-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-natural-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-natural-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-natural-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-natural-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-natural-products 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-natural-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-biologics 2026-08-15T01:35:48+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-biologic-product-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-biologic-products 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-biologic-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-biologic-products 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-biologic-product 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-biologics 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-biologics 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-biologics 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-biologics 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-biologics 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-biologics 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-new-chemical-entity 2026-08-15T01:35:48+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-chemical-entity-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-new-chemical-entity 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-new-chemical-entity 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-new-chemical-entity 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-new-chemical-entity 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-new-chemical-entity 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-new-chemical-entity 2026-08-10T18:10:08+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-health-supplements 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-health-supplements-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-health-supplements 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-health-supplements 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-health-supplements 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-health-supplements 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-health-supplements 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-health-supplements 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-health-supplements 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-health-supplements 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-health-supplements 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-health-supplements 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-veterinary-medicines 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-veterinary-medicines-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-veterinary-medicines 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-veterinary-medicines 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-veterinary-medicines 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-veterinary-medicines 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-1-4-pre-submission-application-preparation-combination-products 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-2-4-submission-new-combination-products-registration 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/product-validation-combination-products 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/section-combination-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-b-combination-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-c-combination-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-d-combination-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-e-combination-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/section-p-combination-products 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/section-s-combination-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/step-3-4-regulatory-outcome-combination-products 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/step-4-4-post-registration-process-combination-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-natural-product 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-natural-product 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-natural-product 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-natural-product 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-natural-product 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-biologics 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-biologics 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-biologics 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-biologics 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-biologics 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-new-chemical-entity 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-new-chemical-entity 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-new-chemical-entity 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-new-chemical-entity 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-health-supplements 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-health-supplements 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-health-supplements 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-health-supplements 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-health-supplements 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-veterinary-medicines 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-veterinary-medicines 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-veterinary-medicines 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-veterinary-medicines 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-1-combination-products 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-2-combination-products 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-3-combination-products 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-4-combination-products 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/pv-5-combination-products 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iii-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iv-new-chemical-entity 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iii-biologic 2026-08-14T07:44:59+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iv-biologic 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/bioequivalence-0 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iv-veterinary 2026-08-11T13:23:11+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iii-veterinary 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/part-iv-veterinary-0 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/laman-utama 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/pengguna 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/ahli-professional-kesihatan 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/industri 2026-08-18T04:45:40+00:00 daily 0.9 https://npra-portal.demosistem.site/asas-regulatori 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/farmakovigillance 2026-08-18T04:45:40+00:00 daily 0.9 https://npra-portal.demosistem.site/lokasi-npra 2026-08-10T06:31:54+00:00 daily 0.9 https://npra-portal.demosistem.site/pengumuman 2026-08-10T06:31:54+00:00 daily 0.9 https://npra-portal.demosistem.site/siaran-akhbar 2026-08-10T06:31:54+00:00 daily 0.9 https://npra-portal.demosistem.site/faqs-combo 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/local-bioequivalence-centre 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/foreign-bioequivalence-centre 2026-08-14T11:48:48+00:00 daily 0.9 https://npra-portal.demosistem.site/be-centressites-which-certificate-has-expired 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/laboratory-quality-control-0 2026-08-18T04:45:40+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-vet-classification 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-vet-coh 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-vet-cos 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-vet-variation 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-vet-renewal 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/skr-empty-1 2026-08-14T10:16:47+00:00 daily 0.9 https://npra-portal.demosistem.site/under-construction-sp-page-builder 2026-08-15T00:45:23+00:00 daily 0.9 https://npra-portal.demosistem.site/ethics-committee-registered-dca 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-drug-medical-device-combination-product-endorsement-letter 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-drug-medical-device-combination-product-general-variation-ancillary-componnent 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-drug-medical-device-combination-product-general-renewal 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faqs-gdp-inspection 2026-08-18T05:20:43+00:00 daily 0.9 https://npra-portal.demosistem.site/ppps-1 2026-08-10T18:10:08+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-combo-general 2026-08-11T13:23:58+00:00 daily 0.9 https://npra-portal.demosistem.site/ppp-1 2026-08-15T00:36:21+00:00 daily 0.9 https://npra-portal.demosistem.site/food-drug-interphase-products 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/medical-device-drug-cosmetic-interphase-products 2026-08-14T10:21:27+00:00 daily 0.9 https://npra-portal.demosistem.site/pkpb-1 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-baru 2026-08-11T13:23:58+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-combo-endorsement-letter 2026-08-11T13:23:58+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-combo-variation-ancillary-component 2026-08-11T13:23:58+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-clinical-trials-safety-reporting 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/new-product-approved-archive 2026-08-14T11:46:44+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-drug-medical-device-combination-product-variation 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/faq-drug-medical-device-combination-product-variation-0 2026-08-14T03:49:37+00:00 daily 0.9 https://npra-portal.demosistem.site/list-accredited-phase-i-units 2026-08-14T11:46:44+00:00 daily 0.9